Payments to Acquire Property, Plant, and Equipment of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
SUPERNUS PHARMACEUTICALS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $327,000, a 32% increase year-over-year.
  • SUPERNUS PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,338,000, a 85% increase from 2024.
  • SUPERNUS PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $725,000, a 32% increase from 2023.
  • SUPERNUS PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $551,000, a 34% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,338,000 +$613,000 +85% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $725,000 +$174,000 +32% 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 $551,000 +$139,000 +34% 01 Jan 2023 31 Dec 2023 10-K 02 Mar 2026 2025 FY
2022 $412,000 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2020 $3,449,000 +$713,000 +26% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2021 2020 FY
2019 $2,736,000 +$1,892,000 +224% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2021 2020 FY
2018 $844,000 -$1,185,000 -58% 01 Jan 2018 31 Dec 2018 10-K 08 Mar 2021 2020 FY
2017 $2,029,000 +$426,000 +27% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $1,603,000 -$501,000 -24% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $2,104,000 +$1,511,000 +255% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $593,000 -$1,053,000 -64% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $1,646,000 +$893,000 +119% 01 Jan 2013 31 Dec 2013 10-K/A 20 Jan 2017 2015 FY
2012 $753,000 +$68,000 +9.9% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $685,000 +$391,000 +133% 01 Jan 2011 31 Dec 2011 10-K 21 Mar 2014 2013 FY
2010 $294,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY

SUPERNUS PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $327,000 +$79,000 +32% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $248,000 -$30,000 -11% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $278,000 -$573,000 -67% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $851,000 -$657,000 -44% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $1,508,000 -$1,029,000 -41% 01 Jan 2021 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q1 2020 $2,537,000 +$2,316,000 +1048% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $221,000 -$32,000 -13% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q1 2018 $253,000 -$47,000 -16% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $300,000 +$21,000 +7.5% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $279,000 +$90,000 +48% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $189,000 -$74,000 -28% 01 Jan 2015 31 Mar 2015 10-Q/A 20 Jan 2017 2016 Q1
Q1 2014 $263,000 -$109,000 -29% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q1 2013 $372,000 +$332,000 +830% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
Q1 2012 $40,000 -$163,000 -80% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q1 2011 $203,000 01 Jan 2011 31 Mar 2011 10-Q 08 Jun 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.